/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.22%
Natural Gas
+5.58%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.91%
VIX
N/A
Economic Calendar
EUR/USD
+0.22%
Natural Gas
+5.58%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.91%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Apple’s Record $110 Billion Buyback Fuels Market Optimism
about 11 hours ago
EIA Natural Gas Storage Build Of +59 Bcf Exceeds Estimates
about 17 hours ago
Initial Claims Stable, Economic Indicators Point to Optimistic Outlook
about 17 hours ago
Binance Founder Changpeng Zhao Bags 4-Month Jail Sentence
1 day ago
Fed Leaves Rate Unchanged, Will Slow The Pace Of Asset Sales
1 day ago
ISM Manufacturing PMI Moved Back Into Contraction Territory In April
1 day ago
EUR/USD, GBP/USD, DXY Price Forecast: DXY Eyes 105.20 Pivot; NFP Ahead
13 minutes ago
Silver (XAG) Daily Forecast: Eyes on $26.82 Pivot as NFP Report Looms
28 minutes ago
XRP Price Forecast: More Consolidation before $0.60 Retest?
41 minutes ago
Gold (XAU) Daily Forecast: Awaits NFP, XAU Holds Near $2,300 Amid Rate Pause
about 2 hours ago
Natural Gas and Oil Forecast: USOIL Eyes $80 Resistance Amid Rally
about 2 hours ago
DAX Index Today: Earnings, the US Jobs Report, and the ISM Services PMI in Focus
about 5 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
RLMD
news
Relmada Therapeutics Inc
Follow
RLMD
(
Nasdaq - US
)
N/A
3.75
+0.06 (+1.63%)
in
:
usd
•
As of: May 02, 2024 15:59
UTC -4
Open
3.76
High
3.76
Low
3.71
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Seeking Alpha
Mar 21, 2024
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
RLMD
+1.63%
Seeking Alpha
Mar 19, 2024
Relmada Therapeutics, Inc. (RLMD) Q4 2023 Earnings Call Transcript
RLMD
+1.63%
Seeking Alpha
Nov 9, 2023
Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript
RLMD
+1.63%
Seeking Alpha
Oct 13, 2023
Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024
RLMD
+1.63%
Zacks Investment Research
Sep 21, 2023
Relmada (RLMD) Up on Positive Data for Anti-Depressant Candidate
RLMD
+1.63%
Seeking Alpha
Sep 1, 2023
Relmada Therapeutics: Run Up Likely Into Phase 3 Results, Enhanced By Possible Interim Readout
RLMD
+1.63%
Seeking Alpha
Aug 9, 2023
Relmada Therapeutics, Inc. (RLMD) Q2 2023 Earnings Call Transcript
RLMD
+1.63%
Seeking Alpha
May 13, 2023
Relmada Therapeutics, Inc. (RLMD) Q1 2023 Earnings Call Transcript
RLMD
+1.63%
Seeking Alpha
Mar 24, 2023
Relmada Therapeutics, Inc. (RLMD) Q4 2022 Earnings Call Transcript
RLMD
+1.63%
Market Watch
Dec 8, 2022
Relmada Therapeutics shares decline 40% on Thursday
RLMD
+1.63%
Seeking Alpha
Nov 12, 2022
Relmada Therapeutics, Inc. (RLMD) Q3 2022 Earnings Call Transcript
RLMD
+1.63%
GuruFocus
Oct 25, 2022
Steven Cohen's Firm Boosts Stakes in Relmada and Immunic
RLMD
+1.63%
Zacks Investment Research
Oct 14, 2022
Relmada (RLMD) Lead Candidate Fails Late-Stage Depression Study
RLMD
+1.63%
InvestorPlace
Oct 13, 2022
Why Is Relmada (RLMD) Stock Down 78% Today?
RLMD
+1.63%
Investors Business Daily
Oct 13, 2022
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
RLMD
+1.63%
Market Watch
Oct 13, 2022
Relmada's stock tumbles 80% after its depressive disorder drug failed a late-stage study
RLMD
+1.63%
Seeking Alpha
Sep 28, 2022
Relmada Therapeutics: Central Nervous System Treatments
RLMD
+1.63%
Seeking Alpha
Sep 14, 2022
Relmada Therapeutics: Initiating With A Strong BUY; Key Phase 3 Short-Term Catalysts Lined Up
RLMD
+1.63%
Seeking Alpha
Aug 14, 2022
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2022 Results - Earnings Call Transcript
RLMD
+1.63%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker